GW-501516 is a chemical compound classified as a selective agonist of the PPARδ receptor (Peroxisome Proliferator-Activated Receptor delta). Originally developed as part of research into the regulation of lipid and glucose metabolism, GW-501516 is now primarily used as a reference substance in laboratory and experimental studies.
Also known as Cardarine, GW-501516 is not approved for medical use.
Research Applications: GW-501516 is used exclusively in laboratory research, including:
-
molecular experiments on the activation of nuclear receptors,
-
analysis of metabolic pathways related to lipid regulation,
-
studies on the effects of PPARδ agonists on gene expression related to energy metabolism in non-clinical models.
No clinical trials have confirmed the safety of GW-501516 in humans, and earlier preclinical studies have indicated potential adverse effects with long-term use in animal models.
Yohimbine HCl (Yohimbine Hydrochloride) is an alkaloid compound derived from naturally occurring yohimbine, which is isolated from the bark of the Pausinystalia yohimbe tree. The synthetic form exists as a hydrochloride salt, characterized by high water solubility, making it suitable for chemical analyses and preclinical research applications.
Research Applications: Yohimbine HCl is used in laboratory settings as a reference chemical in studies of adrenergic receptors, particularly α2-adrenergic receptors. It is commonly employed in experimental models including:
-
pharmacological studies of receptor interactions,
-
analyses of effects on the sympathetic nervous system in preclinical settings,
-
in vitro tests related to neurotransmission and signal modulation.
The products do not have the status of an approved drug, supplement, or food product. They must not be used for medical or cosmetic purposes, or in any form of consumption by humans or animals.
HGH 176-191 is a fragment of the Growth Hormone (GH) molecule, consisting of amino acids 176 to 191 from the full-length GH structure. This hormone fragment is being extensively studied for its potential role in regulating fat metabolism and supporting fat loss. HGH 176-191 does not exhibit the full biological activity of growth hormone due to its incomplete sequence, but in laboratory studies, it shows specific properties that promote fat reduction.
This product is intended solely for research and experimental use in the context of metabolic studies. It is not approved for use in humans or animals for therapeutic purposes.
Research Applications: HGH 176-191 is used exclusively in laboratory research for:
-
studying mechanisms of fat reduction and lipid metabolism regulation,
-
analyzing the peptide’s impact on energy metabolism in model organisms,
-
evaluating its effects on fat-burning mechanisms in the context of obesity and metabolic disorders,
-
investigating interactions between growth hormone fragments and metabolic receptors,
-
testing the potential of HGH 176-191 in studies related to metabolic health and adipose tissue development.
HGH 176-191 is not intended for human or veterinary use in any therapeutic context. The product is strictly for research and experimental purposes only.
